Corvus Pharmaceuticals Inc（CRVS）の株価予測CRVSCorvus Pharmaceuticals Inc

Alphio's CRVS stock price prediction model matches the current Corvus Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $10.32 (+0.84%). The 1-week path is $10.36 (+1.31%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Corvus Pharmaceuticals Inc is currently trading at $9.52, which is significantly below its 200-day simple moving average of $14.277, indicating a bearish trend. The RSI is at 29.901, suggesting that the stock is oversold, but this could also indicate continued downward pressure. The company has a forward P/E of 0, reflecting uncertainty in future earnings, and a recent 5-day change of -9.51% shows a decline in momentum. However, insider David Scott Moore's recent purchase of shares indicates some confidence in the company's future, despite ongoing losses, with a net income of -$17,959,000 in Q2 2026. Given these factors, it may be prudent to hold off on buying until clearer positive signals emerge.

Corvus Pharmaceuticals Inc (CRVS) last closed at $10.23, gaining +6.01%. These facts feed the 1-day and 1-week CRVS price prediction above.